北京招聘

职位描述：
工作职责：
行政方面：
日常行政事务（总机电话，来访客人接待，办公室用品采购）以及机票酒店的预订
协助研发部的总监的行政工作，包括行程和会议安排，报销，其他采购类付款
其他行政经理安排的任务

人事方面：
面试安排
员工出勤记录登记，及时更新员工信息
与人力资源供应商对接，安排员工入离职相关事宜

岗位要求：
大专及以上学历, 行政管理专业、商务英语、人力资源等相关专业；
1-3年的行政助理工作的经验；
高度的责任感，积极主动，踏实勤奋；
良好的沟通能力，热情开朗；
良好的组织协调能力，团队合作和执行力强；
解决问题能力强，特别是能够应对突发事件；对时间管理也有较强的意识；
能够在压力下仍保持积极心态工作；
英语听说读写流利
有一定的办公软件应用能力，包括Outlook, Excel和word等；

Job Responsibilities
Admin functions
Daily administrative affairs (Hotline, welcome the visitors, office supplies purchases ) and office logistics, including booking and organizing transports and accommodations，
Provide secretarial support to R&D Directors, including but not limited to schedule management, reimbursement, payment process,
Other tasks assigned by direct supervisor

HR functions

Interview arrangement and follow up
Record attendance and leave, update staff information in time
Assist in new staff on-board, coordinate with HR vendor


Qualification and Experience
College degree and above, majored in Business, Administration management, English, Human Resource or related
1-3 years related working experience.
High sense of responsibility, proactive, efficient, diligent, hard-working;
Good communication & interpersonal skill,
Strong coordinating and organizing capability, good teamwork and execution ability;
Good problem-solving skills and capable to deal with emergency cases. Strong consciousness for time management.
Willing to work under pressure with pleasant/enthusiasm personality
Fluent in English, both verbal and writing
Computer skill including MS Office, Outlook, Excel and Word etc.

和铂医药是一家专注于肿瘤免疫领域创新药物研究与开发的全球化运营生物医药公司。公司将运用其拥有的全部自主知识产权的全人源单抗的转基因鼠系列核心技术平台，建立下一代治疗性肿瘤抗体药物产品管线,并将围绕Harbour的两大平台拓展合作与授权业务。公司总部及研发基地位于中国上海，另外在美国马塞诸塞州剑桥设立商业运营中心，在荷兰鹿特丹设立抗体研发平台创新中心，在波士顿地区设立了创新中心包括实验室和研发团队，也将在江苏昆山设立研发基地。公司拥有资深管理团队以及丰富的药物研究与开发经验。和铂医药要为满足中国及全球病人的需求而不断努力，依托拥有自主知识产权的核心技术平台,创建一个在肿瘤治疗领域有科学与技术领导力的国际性生物医药公司。同时, 在药物研发领域建立以技术平台为基础的对外合作，整合新的技术，推动中国整个抗体研发产业的进步。

Company Overview
Harbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer with a focus on immuno-oncology and autoimmunity/inflammation. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery.
The company is building its proprietary pipeline internally, through collaborations with co-development partners, as well as through selective preclinical and clinical stage asset acquisitions. Harbour BioMed also licenses the platforms to companies and academic institutions through its Harbour Antibodies subsidiary.
Harbour BioMed has headquarters and an R&D site in Shanghai, business operations in Cambridge, MA, and antibody platform development in Rotterdam, The Netherlands.
The company has an innovation center including research lab and a development team in Boston. Also, we are expanding to Kunshan site in Jiangsu for our R&D operation.